Maglangit, Isaac T.
HRN: 28-68-36 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2026
MUPIROCIN 2%, 15G (TUBE)
03/09/2026
03/15/2026
TOPICAL
2%
BID
Abrasion Right Knee
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: